Meta AI's Advances, OpenAI's Safeguards, and BigHat Biosciences' Precision Medicine

In this episode, Michelle starts by introducing the day's topics before diving into Meta AI's latest research updates and new models, shedding light on their potential impact. She then discusses OpenAI's introduction of new safeguards and efforts to engage with the community, emphasizing the importance of AI safety. The episode also covers the national security implications and data siphoning concerns associated with DeepSeek's technology. Additionally, Michelle explores the partnership between BigHat Biosciences and Eli Lilly, focusing on advancements in precision medicine. The episode wraps up with closing remarks and a reminder for listeners to subscribe for more AI news updates.